Bausch Health Companies (BHC) Retained Earnings (2009 - 2026)
Bausch Health Companies (BHC) reported Retained Earnings of -$11.1 billion for Q1 2026, down 446.57% on a YoY basis from $3.2 billion in Q1 2025, and down 14.72% sequentially from -$9.7 billion in Q4 2025.
Bausch Health Companies (BHC) Retained Earnings (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Retained Earnings data on file, last reported at -$11.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 446.57% year-over-year to -$11.1 billion; the trailing twelve-month figure through Mar 2026 stood at -$11.1 billion (down 446.57% YoY), and the FY2025 full-year result was -$9.7 billion, up 1.6% from the prior year.
- Retained Earnings slipped to -$11.1 billion in Q1 2026, from -$9.7 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$1.8 billion in Q2 2025 to a low of -$11.1 billion in Q1 2026.
- A 5-year average of -$7.4 billion and a median of -$9.4 billion in 2023 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings jumped 81.85% in 2025 and slumped 446.57% in 2026, its largest moves.
- Tracing BHC's Retained Earnings over 5 years: stood at -$9.2 billion in 2022, then retreated by 6.44% to -$9.8 billion in 2023, then declined by 0.47% to -$9.8 billion in 2024, then gained by 1.6% to -$9.7 billion in 2025, then fell by 14.72% to -$11.1 billion in 2026.
- Business Quant data shows BHC's Retained Earnings at -$11.1 billion in Q1 2026, -$9.7 billion in Q4 2025, and -$1.8 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | -11.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.09 Bn |
| Dec 31, 2025 | -9.67 Bn |
| Sep 30, 2025 | -1.80 Bn |
| Jun 30, 2025 | -1.79 Bn |
| Mar 31, 2025 | -2.03 Bn |
| Dec 31, 2024 | -9.82 Bn |
| Sep 30, 2024 | -9.92 Bn |
| Jun 30, 2024 | -9.83 Bn |
| Mar 31, 2024 | -9.84 Bn |
| Dec 31, 2023 | -9.78 Bn |
| Sep 30, 2023 | -2.05 Bn |
| Jun 30, 2023 | -9.36 Bn |
| Mar 31, 2023 | -9.39 Bn |
| Dec 31, 2022 | -9.19 Bn |
| Sep 30, 2022 | -2.27 Bn |
| Jun 30, 2022 | -9.18 Bn |
| Mar 31, 2022 | -9.03 Bn |
| Dec 31, 2021 | -8.96 Bn |
| Sep 30, 2021 | -9.03 Bn |
| Jun 30, 2021 | -9.22 Bn |